本文へスキップ
  • ログイン
    ようこそ！
    マイアカウント
    ログアウト

VivoSim Labs, INC. (ONVO) 株価予測 2025 - AI価格予測と分析

VivoSim Labs, INC. (ONVO) AI株価予測と投資分析

VivoSim Labs, INC. 株価チャートとテクニカル分析

VAR_0__ インタラクティブ価格チャートとテクニカル分析をロード中...

VivoSim Labs, INC. (ONVO) - 包括的な株式分析と投資調査

Deep dive into VivoSim Labs, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about VivoSim Labs, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

VAR_0__の場合: VivoSim Labs, INC. operates in the Life Sciences sector, making it an emerging small-cap investment.

VivoSim Labs, INC. (銘柄記号: ONVO) は、VAR_0セクターの大手企業である。 具体的には、VAR_0業界内で事業を行っている。.

この組織では、世界中でおよそ_6_の専門家を雇用している。 .

同社 としての地位を確立している。 大きな成長の可能性を秘めた新たな投資機会.

Understanding Financial Performance

これらの指標が意味するもの: Key financial indicators showing VivoSim Labs, INC.'s revenue scale, profitability, market value, and shareholder returns.

読み方: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

VAR_0__の場合: With $1M in annual revenue and -1135.0% net margin, the company demonstrates developing profitability.

年間収入: $1 百万 VAR_0___%純利益率を生み出す .

時価総額: $35 百万 - に分類される。 高成長が期待できる小型株投資.

株主資本利益率（ROE）: -33.0% - 平均以下 株主還元の効率性を示す 業務改善分野.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for VivoSim Labs, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

VAR_0__の場合: Unlock premium access to view detailed AI predictions and price targets.

🚀 プレミアムAI予測のアンロック をクリックすると、VivoSim Labs, INC.株の7日間、30日間、90日間の目標株価と信頼区間、リスク評価を含む高度な機械学習予測にアクセスできます。

Understanding Market Position

What this analysis covers: VivoSim Labs, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

VAR_0__の場合: Market positioning analysis based on available financial and operational metrics.

VAR_0__は、非常にダイナミックな業界で戦略的に競争している。 VAR_0__ 市場, 実質的な成長ポテンシャルと市場破壊能力を備えた新興小型株への投資。 .

同社は健全な85.1_%粗利益率を維持しており、これは強力な価格決定力と経営効率を示している。

VivoSim Labs, INC. (ONVO) ファンダメンタル分析とインサイダー取引データ (四半期財務報告)

四半期ごとの包括的な財務データ、業績動向、インサイダー取引、機関投資家の保有銘柄を掲載しています。 VivoSim Labs, INC. 株式分析.

ロード VivoSim Labs, INC. 包括的なファンダメンタル分析とインサイダー取引データ...

VAR_0__の財務の健全性、評価指標、経営効率を深く掘り下げ、十分な情報に基づいた投資判断を行う。

評価指標を理解する

これらの指標が意味するもの: バリュエーション評価指標は、VivoSim Labs, INC.株が収益、資産、市場での地位と比較して適正な価格であるかどうかを判断するのに役立ちます。

読み方: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

VAR_0__の場合: PERが-0.36の場合、市場は-0.36となる。 は株価が割安になる可能性があると見ている。.

P/E Ratio -0.36x
P/B Ratio 95.90x
Market Cap $35M
EPS $-1.05
簿価/株 $0.02
収益/シェア $0.06
FCF/シェア $-2.22
収益性指標を理解する

これらの指標が意味するもの: これらの比率は、VivoSim Labs, INC.がいかに効率的に収益を利益に変換し、株主へのリターンを生み出しているかを測るものである。

読み方: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

VAR_0__の場合: ROEは-33.0_%。 に改善の余地があることを示している。 株主価値創造.

ROE -33.0%
ROA -31.3%
ROIC -31.1%
Gross Margin 85.1%
Operating Margin -1155.7%
Net Margin -1135.0%
EBT Margin -763.1%
財務健全性指標を理解する

これらの指標が意味するもの: これらの比率は、VivoSim Labs, INC.の短期債務を履行し、債務水準を効果的に管理する能力を評価するものである。

読み方: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

VAR_0__の場合: 流動比率は21.35。 は強い流動性を示す.

Current Ratio 21.35x
Quick Ratio 20.73x
D/E Ratio 0.06x
Financial Leverage 1.10x
Interest Coverage -39.0x
Working Capital $38M
キャッシュフロー指標の理解

これらの指標が意味するもの: キャッシュフロー指標は、VivoSim Labs, INC.が事業からキャッシュを生み出し、成長イニシアチブに資金を供給する能力を明らかにする。

読み方: プラスの営業キャッシュフローは極めて重要である。フリー・キャッシュ・フローは、配当、自社株買い、投資に利用できる資金を示す。

VAR_0__の場合: フリー・キャッシュフロー $-9M は注意が必要な現金の課題を示す.

Operating Cash Flow $-8M
Free Cash Flow $-9M
FCF/Sales -590.8%
CapEx/Sales 27.3%
業務効率指標を理解する

これらの指標が意味するもの: これらの比率は、VivoSim Labs, INC.がいかに効果的に資産を使用し、運転資本を管理しているかを測るものである。

読み方: 回転率が高いほど、効率的な資産活用を示す。回収期間の短縮は、効果的な与信管理を示す。

VAR_0__の場合: 資産回転率 0.04x に改善の余地があることを示唆している。 資産活用.

Asset Turnover 0.04x
Receivables Turnover 7.2x
Inventory Turnover 1.3x
Fixed Assets Turnover 0.9x
売上日数 51 日
在庫日数 273 日
支払期間 750 日
現金化サイクル -426 日
財務諸表データの理解

これらの指標が意味するもの: VAR_0__の損益計算書および貸借対照表から、絶対的な財務実績を示す主な数値。

読み方: 売上高は事業規模を示し、利益率は収益性を示す。貸借対照表項目は財務構造を示す。

VAR_0__の場合: 年間収益が$1Mで、VivoSim Labs, INC.。 は、規模は小さいが潜在的な高成長事業である。.

損益計算書 ($ 百万ドル)
総収入 $1M
営業利益 $-12M
純利益 $-12M
研究開発費 $5M
販管費 $642M
貸借対照表ハイライト (% Of Assets)
Total Current Assets 89%
Cash & Short-term Investments 86%
Total Liabilities 9%
Accounts Receivable 0%
Inventory 1%
配当・株主情報
Shares Outstanding 17M
成長指標（前年同期比）
EPS Growth -228.3%

最新 VivoSim Labs, INC. 株式ニュース＆市場分析

速報ニュース、アナリストレポート、VivoSim Labs, INC. (ONVO) の株価や投資見通しに影響を与える市場の最新情報。

, ソース: Investing

VivoSim Labs names Tony Lialin as chief commercial officer SAN DIEGO - Pharmaceutical and biotechnology services company VivoSim Labs, Inc. (NASDAQ:VIVS), currently valued at $4.84 million ...

, ソース: CNN

View VivoSim Labs Inc VIVS stock quote prices, financial information, real-time forecasts, and company news from CNN.

VivoSim Labs, INC. 競合他社・同業他社分析 - Life Sciences セクター

VAR_0__セクターの同業他社および競合他社に対するVivoSim Labs, INC.の比較分析、AIを活用した予測および主要財務指標を掲載。

会社概要 ティッカーシンボル 90日間のAI予測 時価総額 (USD M) PER（株価収益率 PBR（株価純資産倍率
ABOS Unlock Forecast - 30 Days FREE Trial $85M -1.9x 0.7x
ABP Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ABPWW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ACLX Unlock Forecast - 30 Days FREE Trial $3725M -74.1x 8.9x
ACOG Unlock Forecast - 30 Days FREE Trial $143M x 4.5x
ADAP Unlock Forecast - 30 Days FREE Trial $65M -13.2x -11.8x
ADMA Unlock Forecast - 30 Days FREE Trial $4035M 19.3x 10.1x
ADPT Unlock Forecast - 30 Days FREE Trial $1901M -4.6x 10.6x
ADVM Unlock Forecast - 30 Days FREE Trial $58M -1.8x 2.2x
AGEN Unlock Forecast - 30 Days FREE Trial $130M -0.5x -0.5x
AIM Unlock Forecast - 30 Days FREE Trial $2M -0.5x -183.3x
AIMI Unlock Forecast - 30 Days FREE Trial $2M x x
ALEC Unlock Forecast - 30 Days FREE Trial $305M -1.2x 4.3x
ALGS Unlock Forecast - 30 Days FREE Trial $107M -19.2x 1.1x
ALLO Unlock Forecast - 30 Days FREE Trial $253M -1.4x 0.7x
ALVR Unlock Forecast - 30 Days FREE Trial $49M -0.5x 0.4x
AMGN Unlock Forecast - 30 Days FREE Trial $151583M 22.9x 20.4x
APGE Unlock Forecast - 30 Days FREE Trial $2240M -20.5x 4.3x
APTO Unlock Forecast - 30 Days FREE Trial $6M 0.0x -1.3x
APTOF Unlock Forecast - 30 Days FREE Trial $3M x x
ARMP Unlock Forecast - 30 Days FREE Trial $103M -1.0x -1.6x
ARTV Unlock Forecast - 30 Days FREE Trial $88M x 0.6x
ATHA Unlock Forecast - 30 Days FREE Trial $15M -0.2x 0.5x
ATRA Unlock Forecast - 30 Days FREE Trial $149M 25.8x -1.1x
ATYR Unlock Forecast - 30 Days FREE Trial $515M -3.6x 6.9x
AURA Unlock Forecast - 30 Days FREE Trial $402M -4.9x 2.3x
AUTL Unlock Forecast - 30 Days FREE Trial $389M x 1.1x
AVXL Unlock Forecast - 30 Days FREE Trial $803M -17.3x 8.8x
BCAB Unlock Forecast - 30 Days FREE Trial $125M -1.1x 1.0x
BCDA Unlock Forecast - 30 Days FREE Trial $12M -0.6x -7.8x
BCLI Unlock Forecast - 30 Days FREE Trial $7M -4.9x -0.9x
BCRX Unlock Forecast - 30 Days FREE Trial $1802M -12.1x -4.0x
BDTX Unlock Forecast - 30 Days FREE Trial $171M 11.8x 1.3x
BEAM Unlock Forecast - 30 Days FREE Trial $1979M -12.6x 1.9x
BIIB Unlock Forecast - 30 Days FREE Trial $18125M 12.8x 1.5x
BKHA Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BKHAU Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BLUE Unlock Forecast - 30 Days FREE Trial $49M -0.2x -0.8x
CABA Unlock Forecast - 30 Days FREE Trial $155M -1.6x 0.9x
CADL Unlock Forecast - 30 Days FREE Trial $338M -4.6x 4.5x
CCCC Unlock Forecast - 30 Days FREE Trial $193M -2.6x 1.1x
CDTX Unlock Forecast - 30 Days FREE Trial $728M -1.0x 5.1x
CELZ Unlock Forecast - 30 Days FREE Trial $9M -3.4x 1.3x
CERO Unlock Forecast - 30 Days FREE Trial $2M x -196.2x
CEROW Unlock Forecast - 30 Days FREE Trial $2M x -0.5x
CGEM Unlock Forecast - 30 Days FREE Trial $449M -4.1x 0.8x
CGEN Unlock Forecast - 30 Days FREE Trial $134M x 2.7x
CGON Unlock Forecast - 30 Days FREE Trial $2502M x 3.7x
CGTX Unlock Forecast - 30 Days FREE Trial $170M -0.5x 24.1x
CHRO Unlock Forecast - 30 Days FREE Trial $8M x -2.0x
CHRS Unlock Forecast - 30 Days FREE Trial $150M 0.8x 1.3x
CLDI Unlock Forecast - 30 Days FREE Trial $5M -0.9x 3.1x
CMPX Unlock Forecast - 30 Days FREE Trial $483M -4.8x 5.2x
COEPW Unlock Forecast - 30 Days FREE Trial $M x x
CRBU Unlock Forecast - 30 Days FREE Trial $174M -1.5x 1.1x
CRDF Unlock Forecast - 30 Days FREE Trial $144M -4.0x 2.5x
CRGX Unlock Forecast - 30 Days FREE Trial $215M x 0.9x
CRIS Unlock Forecast - 30 Days FREE Trial $18M -0.3x -2.9x
CRSP Unlock Forecast - 30 Days FREE Trial $4781M -12.1x 2.8x
CSBR Unlock Forecast - 30 Days FREE Trial $111M -17.8x 20.4x
CVM Unlock Forecast - 30 Days FREE Trial $56M -0.9x 8.0x
CYTH Unlock Forecast - 30 Days FREE Trial $26M -0.6x -1.9x
CYTHW Unlock Forecast - 30 Days FREE Trial $7M x -0.5x
DBVT Unlock Forecast - 30 Days FREE Trial $1479M -3.3x 514.8x
DNA Unlock Forecast - 30 Days FREE Trial $568M -13.9x 0.3x
DNLI Unlock Forecast - 30 Days FREE Trial $2111M -8.7x 1.9x
DTIL Unlock Forecast - 30 Days FREE Trial $59M -2.2x 1.7x
DYAI Unlock Forecast - 30 Days FREE Trial $28M -7.3x 11.4x
EDIT Unlock Forecast - 30 Days FREE Trial $231M -0.8x 3.7x
ELEV Unlock Forecast - 30 Days FREE Trial $22M -1.0x 0.5x
ELUT Unlock Forecast - 30 Days FREE Trial $84M -1.4x -0.1x
ENGN Unlock Forecast - 30 Days FREE Trial $276M 3.7x 1.2x
ENGNW Unlock Forecast - 30 Days FREE Trial $37M x 0.1x
ENTX Unlock Forecast - 30 Days FREE Trial $94M 8.5x 5.4x
ENZ Unlock Forecast - 30 Days FREE Trial $25M -3.0x 0.5x
ENZB Unlock Forecast - 30 Days FREE Trial $37M x 0.8x
ESLA Unlock Forecast - 30 Days FREE Trial $39M -3.1x -16.9x
ESLAW Unlock Forecast - 30 Days FREE Trial $4M x 5.3x
EXEL Unlock Forecast - 30 Days FREE Trial $10790M 17.9x 5.3x
EXOZ Unlock Forecast - 30 Days FREE Trial $100M x 13.9x
FATE Unlock Forecast - 30 Days FREE Trial $115M -1.3x 0.4x
FDMT Unlock Forecast - 30 Days FREE Trial $406M -3.0x 1.0x
FENC Unlock Forecast - 30 Days FREE Trial $250M 1758.3x -39.7x
FNCH Unlock Forecast - 30 Days FREE Trial $20M -0.1x 1.4x
FTII Unlock Forecast - 30 Days FREE Trial $-26M x -0.7x
FTIIU Unlock Forecast - 30 Days FREE Trial $-26M x -0.8x
FTIIW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
GILD Unlock Forecast - 30 Days FREE Trial $145661M 23.1x 7.4x
GLUE Unlock Forecast - 30 Days FREE Trial $398M 16.5x 1.5x
GNTA Unlock Forecast - 30 Days FREE Trial $64M x 5.1x
GPLB Unlock Forecast - 30 Days FREE Trial $M x x
HALO Unlock Forecast - 30 Days FREE Trial $9516M 17.1x 28.6x
HLVX Unlock Forecast - 30 Days FREE Trial $105M -0.6x 0.7x
HUMA Unlock Forecast - 30 Days FREE Trial $224M -3.3x 55.2x
HUMAW Unlock Forecast - 30 Days FREE Trial $163M x -2.6x
IBRX Unlock Forecast - 30 Days FREE Trial $2427M -3.6x -4.1x
IKNA Unlock Forecast - 30 Days FREE Trial $61M -1.3x 0.5x
IKT Unlock Forecast - 30 Days FREE Trial $150M -1.0x 1.9x
IMCR Unlock Forecast - 30 Days FREE Trial $1827M x 4.7x
IMVT Unlock Forecast - 30 Days FREE Trial $2803M -14.5x 4.6x
INAB Unlock Forecast - 30 Days FREE Trial $21M -0.4x 2.4x
INBX Unlock Forecast - 30 Days FREE Trial $436M -6.8x 6.4x
INKT Unlock Forecast - 30 Days FREE Trial $59M -1.5x -1.4x
INMB Unlock Forecast - 30 Days FREE Trial $52M -2.5x 1.8x
INTS Unlock Forecast - 30 Days FREE Trial $7M -2.2x 3.4x
IOVA Unlock Forecast - 30 Days FREE Trial $851M -4.5x 1.2x
IPSC Unlock Forecast - 30 Days FREE Trial $44M -0.7x 0.2x
ITOS Unlock Forecast - 30 Days FREE Trial $393M -2.8x 0.7x
IVVD Unlock Forecast - 30 Days FREE Trial $137M -0.4x 3.2x
IZTC Unlock Forecast - 30 Days FREE Trial $99M x -27.5x
JSPR Unlock Forecast - 30 Days FREE Trial $44M -3.2x 1.9x
JSPRW Unlock Forecast - 30 Days FREE Trial $3M x 0.0x
KLRS Unlock Forecast - 30 Days FREE Trial $86M x 1.6x
KLTO Unlock Forecast - 30 Days FREE Trial $26M x 2.4x
KLTOW Unlock Forecast - 30 Days FREE Trial $1M x 0.4x
KOD Unlock Forecast - 30 Days FREE Trial $556M -2.5x 7.9x
KRBPQ Unlock Forecast - 30 Days FREE Trial $0M x x
KRYS Unlock Forecast - 30 Days FREE Trial $4330M 29.5x 4.2x
KYMR Unlock Forecast - 30 Days FREE Trial $3533M -17.8x 3.6x
KYTX Unlock Forecast - 30 Days FREE Trial $170M x 0.9x
LADX Unlock Forecast - 30 Days FREE Trial $M x x
LCTX Unlock Forecast - 30 Days FREE Trial $271M -4.7x 5.6x
LENZ Unlock Forecast - 30 Days FREE Trial $1196M -6.7x 5.8x
LIMN Unlock Forecast - 30 Days FREE Trial $0M x x
LXEO Unlock Forecast - 30 Days FREE Trial $271M -0.4x 2.0x
MAZE Unlock Forecast - 30 Days FREE Trial $696M x 2.7x
MGTX Unlock Forecast - 30 Days FREE Trial $693M -3.4x 20.9x
MGX Unlock Forecast - 30 Days FREE Trial $72M x 0.4x
MRNA Unlock Forecast - 30 Days FREE Trial $9659M -3.2x 1.0x
NBIX Unlock Forecast - 30 Days FREE Trial $14639M 42.0x 5.4x
NKGN Unlock Forecast - 30 Days FREE Trial $4M -0.1x -0.2x
NKGNW Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
NMRA Unlock Forecast - 30 Days FREE Trial $271M -3.9x 1.5x
NVAX Unlock Forecast - 30 Days FREE Trial $1417M 3.4x 37.7x
OCGN Unlock Forecast - 30 Days FREE Trial $298M -4.3x 18.7x
OMGA Unlock Forecast - 30 Days FREE Trial $9M -0.7x 0.8x
OMGAQ Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
ONVO Unlock Forecast - 30 Days FREE Trial $35M -0.4x 95.9x
OTLK Unlock Forecast - 30 Days FREE Trial $73M -0.2x -2.3x
PALI Unlock Forecast - 30 Days FREE Trial $4M -0.2x 0.7x
PASG Unlock Forecast - 30 Days FREE Trial $23M -0.6x 0.6x
PCVX Unlock Forecast - 30 Days FREE Trial $4403M -20.4x 1.4x
PHGE Unlock Forecast - 30 Days FREE Trial $14M 1.5x 0.7x
PLUR Unlock Forecast - 30 Days FREE Trial $-4M -1.4x -9.1x
PLX Unlock Forecast - 30 Days FREE Trial $120M 19.1x 2.4x
PMCB Unlock Forecast - 30 Days FREE Trial $7M -2.6x 0.2x
PRME Unlock Forecast - 30 Days FREE Trial $500M -1.5x 8.2x
PROK Unlock Forecast - 30 Days FREE Trial $-62M x 0.0x
PSTX Unlock Forecast - 30 Days FREE Trial $926M -9.6x 10.6x
PTHS Unlock Forecast - 30 Days FREE Trial $M x x
QGEN Unlock Forecast - 30 Days FREE Trial $10692M x 3.0x
QNCX Unlock Forecast - 30 Days FREE Trial $86M -1.7x 7.4x
REPL Unlock Forecast - 30 Days FREE Trial $932M -3.8x 2.2x
RGEN Unlock Forecast - 30 Days FREE Trial $6531M 8219.1x 3.3x
RGNX Unlock Forecast - 30 Days FREE Trial $499M -1.8x 2.3x
RLAY Unlock Forecast - 30 Days FREE Trial $707M -2.0x 1.1x
RVMD Unlock Forecast - 30 Days FREE Trial $7134M -11.1x 3.4x
RVMDW Unlock Forecast - 30 Days FREE Trial $16M x 0.0x
RXRX Unlock Forecast - 30 Days FREE Trial $2019M -4.7x 2.2x
SABS Unlock Forecast - 30 Days FREE Trial $24M -2.3x 1.1x
SABSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
SANA Unlock Forecast - 30 Days FREE Trial $697M -2.1x 5.7x
SCLX Unlock Forecast - 30 Days FREE Trial $62M -0.4x -0.3x
SCLXW Unlock Forecast - 30 Days FREE Trial $25M x -0.1x
SCNI Unlock Forecast - 30 Days FREE Trial $9674M -287.8x 1231.2x
SGMO Unlock Forecast - 30 Days FREE Trial $131M -1.6x 6.7x
SLDB Unlock Forecast - 30 Days FREE Trial $495M -0.9x 1.7x
SLXN Unlock Forecast - 30 Days FREE Trial $4M x 34.5x
SLXNW Unlock Forecast - 30 Days FREE Trial $866M x -189.1x
SNTI Unlock Forecast - 30 Days FREE Trial $51M -1.1x 1.3x
SRRK Unlock Forecast - 30 Days FREE Trial $4069M -18.5x 13.0x
SRZN Unlock Forecast - 30 Days FREE Trial $105M -0.5x 2.2x
SRZNW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
STRO Unlock Forecast - 30 Days FREE Trial $90M -1.0x -2.5x
SWTX Unlock Forecast - 30 Days FREE Trial $3539M -9.9x 8.5x
TARA Unlock Forecast - 30 Days FREE Trial $131M -2.1x 0.9x
TARS Unlock Forecast - 30 Days FREE Trial $2390M -12.4x 7.2x
TCBP Unlock Forecast - 30 Days FREE Trial $37M x 34.5x
TCBPW Unlock Forecast - 30 Days FREE Trial $1M x 1.0x
TCBPY Unlock Forecast - 30 Days FREE Trial $13M x 12.0x
TCRX Unlock Forecast - 30 Days FREE Trial $248M -4.6x 1.4x
TECH Unlock Forecast - 30 Days FREE Trial $8155M 75.2x 4.0x
TECX Unlock Forecast - 30 Days FREE Trial $314M -8.9x 1.1x
TIL Unlock Forecast - 30 Days FREE Trial $182M -1.1x 1.3x
TNYA Unlock Forecast - 30 Days FREE Trial $184M -2.5x 1.9x
TRML Unlock Forecast - 30 Days FREE Trial $688M -3.5x 2.7x
TSBX Unlock Forecast - 30 Days FREE Trial $8M -0.1x 0.6x
TSHA Unlock Forecast - 30 Days FREE Trial $919M -3.0x 3.7x
TTNP Unlock Forecast - 30 Days FREE Trial $8M -0.5x 4.5x
TVGN Unlock Forecast - 30 Days FREE Trial $168M x -29.3x
TVGNW Unlock Forecast - 30 Days FREE Trial $11M x -1.9x
TWST Unlock Forecast - 30 Days FREE Trial $1487M -12.6x 3.1x
VACH Unlock Forecast - 30 Days FREE Trial $-1436M x 0.0x
VACHU Unlock Forecast - 30 Days FREE Trial $-1585M x 0.0x
VCEL Unlock Forecast - 30 Days FREE Trial $1655M 232.9x 5.4x
VIGL Unlock Forecast - 30 Days FREE Trial $384M -1.1x 9.3x
VIR Unlock Forecast - 30 Days FREE Trial $732M -2.0x 0.8x
VIVS Unlock Forecast - 30 Days FREE Trial $3M x 0.3x
VOR Unlock Forecast - 30 Days FREE Trial $246M -0.6x 3.9x
VXRT Unlock Forecast - 30 Days FREE Trial $87M -0.9x 2.7x
VYGR Unlock Forecast - 30 Days FREE Trial $248M 570.6x 1.0x
WINT Unlock Forecast - 30 Days FREE Trial $18M -0.4x 4.2x
XFOR Unlock Forecast - 30 Days FREE Trial $8M 6.4x 0.4x
ZIVO Unlock Forecast - 30 Days FREE Trial $57M -31.3x -2.0x
ZURA Unlock Forecast - 30 Days FREE Trial $131M 5.0x 0.9x

よくある質問 - VivoSim Labs, INC. 株価予想

VAR_0__株価予測の精度は？

Our AI model demonstrates 33% historical accuracy for ONVO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

VAR_0__株価予測に影響を与える要因は何か？

当社の分析では、VivoSim Labs, INC.の財務指標、Life Sciencesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。

2025年、VivoSim Labs, INC.は良い投資先か？

AIの分析によると、VivoSim Labs, INC.は次のようになる。 さまざまな市場シナリオの可能性. 投資の意思決定を行う前に、リスク許容度、投資スケジュール、ポートフォリオの分散を考慮してください。

VAR_0__予想の更新頻度は？

VAR_0__株価予測は、リアルタイムの市場データを使用して毎日更新され、AIを駆使した最新の予測と投資に関する洞察を確実にお届けします。

より高度なVivoSim Labs, INC.分析が必要ですか？

VAR_0__株の詳細な目標株価、リスク評価、ポートフォリオの最適化、リアルタイムのアラートなど、プレミアム機能のロックを解除します。

🎯 プレミアム分析 📊 その他の銘柄を見る

私のポートフォリオ

投資ダッシュボード

ポートフォリオを読み込む...